Dignify Therapeutics

Dignify Therapeutics Adds Two New Members to its Scientific Advisory Board

RESEARCH TRIANGLE PARK, NC (RTP) – February 3, 2015 – Dignify Therapeutics, LLC, announced that Michael Jay, PhD, and Kristy Borawski, MD, have joined Dignify’s scientific advisory board. Dr. Jay is the Fred Eshelman Distinguished Professor of Molecular Pharmaceutics, and Division Chair at the Eshelman School of Pharmacy at University of North Carolina, Chapel Hill. Dr. Borawski is currently Assistant Professor in the Urology Department at the University of North Carolina, Chapel Hill.

Dr. Jay has over 30 years of experience working in pharmaceutics. He is internationally known for his work in pharmaceutical science and pharmaceutical product development where he uses many approaches to solve problems encountered in the development of novel formulations and drug delivery systems.

Dr. Borawski is committed to providing comprehensive, quality of life-driven and compassionate care to her patients and specializes in female urology, urodynamics, neurourology, and female/male incontinence.

“The inability to void urine can require a lifetime of multiple daily catheterizations of the bladder with attendant risks of infections, as well as financial, physical, and social burdens,” according to Dr. Karl Thor, Chief Scientific Officer of Dignify Therapeutics. He added, “We are incredibly fortunate to add Dr. Borawski, an internationally- recognized clinician to our team as we prepare for clinical trials. We are equally fortunate to add Dr. Jay, an internationally-recognized expert in formulation development as we explore the most convenient and cost-effective methods of delivery for our lead candidate, DTI-100, to patients with voiding dysfunction. The local availability of these scientists makes for a convenient working relationship and is a tribute to Research Triangle Park’s access to such fine academic institutions such as UNC-CH.”

About Dignify Therapeutics LLC
Founded by a team of serial entrepreneurs who are internationally-recognized scientists and clinicians, Dignify Therapeutics’ mission is to provide safe, effective, practical and convenient, “on-demand” pharmaceutical agents to treat bladder and bowel voiding dysfunctions, using a repositioning strategy of drug discovery that the team has successfully implemented multiple times over the last 20 years in the fields of urology and gastroenterology. Funding has been provided by the North Carolina Biotechnology Center, an entity primarily funded by the State of North Carolina and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dignify is a member of the Blackstone Entrepreneur Network and is located at the First Flight Venture Center in Research Triangle Park, North Carolina.

Dignify Therapeutics
Benny Ward
P.O. Box 13169 – 2 Davis Drive
Research Triangle Park, NC 27709
Phone: 919-491-0369
Email: bward@dignifytherapeutics.com
Website: http://dignifytherapeutics.com